Deepmedchem
Founded 2023 · 10 employees on LinkedIn · 1 known investors
Find your way into Deepmedchem
67 people in our graph share verified history with the Deepmedchem team — schools, employers, funds. One of them is your warm intro.
Michal Taborskyunlockedknows Jan Macek · together at Czech Technical University in Prague (overlapped)
knows the team · via Charles University
×7knows the team · via Czech Technical University in Prague
×2knows the team · via Clearstream
knows the team · via Milwaukee School of Engineering
Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
Founders & leadership
JM
Jan MacekinChief Executive OfficerJan Macek leads Deep MedChem, a spin-off from collaboration between The MAMA AI team (with ex-IBM Watson and IBM Research researchers) and the Institute of Organic Chemistry and Biochemistry in Prague, developing AI and machine learning methods for drug discovery and medicinal chemistry. He also serves as co-founder and co-CEO at The MAMA AI and director of services at TELMA AI.
ML
Miroslav LžičařinChief Technical OfficerMiroslav Lžičař is Chief Technical Officer at Deep MedChem, an AI drug discovery platform spin-off from The MAMA AI and IOCB medicinal chemistry institute, where he has developed vector-space molecular search systems and transformer architectures for chemical space exploration. His background spans research engineering roles in machine learning, information retrieval, and scientific AI systems.
JR
Jiří RůžičkainChief Business OfficerJiří Růžička is Chief Business Officer at Deep MedChem, an AI drug discovery platform spin-off from IOCB Prague's medicinal chemistry institute. He leads business development for the company's chemical search and design tools.
Investors · 1
Frequently asked questions
- What does Deepmedchem do?
- Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
- Who are Deepmedchem's investors?
- Deepmedchem's investors include Biotech Investments S.R.O.